xanthenes has been researched along with Vaccinia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carr, AA; Fleming, RW; Grisar, JM; Grunwell, JF; Mayer, GD; Meyer, DR; Scheve, BJ; Sill, AD; Sweet, FW | 1 |
1 other study(ies) available for xanthenes and Vaccinia
Article | Year |
---|---|
Bis-basic-substituted polycyclic aromatic compounds. A new class of antiviral agents. 7. Bisalkamine esters of 9-oxoxanthene-2,7-dicarboxylic acid, 3,6-bis-basic ethers of xanthen-9-one, and 2,7-bis(aminoacyl)xanthen-9-ones-xanthenes, and -thioxanthenes.
Topics: Administration, Oral; Animals; Antiviral Agents; Encephalitis; Encephalomyocarditis virus; Enterovirus Infections; Injections, Subcutaneous; Male; Mice; Semliki forest virus; Structure-Activity Relationship; Time Factors; Vaccinia; Xanthenes | 1976 |